Welcome to UCB in Canada

Media & Funding

Media & Funding

Welcome to UCB's media room. This section offers resources for journalists, editors and other media professionals.

Blog

Latest News

07/16/2024
BIMZELX® (bimekizumab)

Now Approved for Adults with Active Psoriatic Arthritis and for Adults with Axial Spondyloarthritis

LEARN MORE

Media Relations for UCB Canada

If you are a member of the media and require further information about UCB Canada Inc. or its products, please contact: mediacanada@ucb.com.